Instadose Pharma Corp Stock Current Valuation
| INSD Stock | USD 0 0.00 0.00% |
Valuation analysis of Instadose Pharma Corp helps investors to measure Instadose Pharma's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The current year's Enterprise Value is expected to grow to about 1.7 B, whereas Enterprise Value Over EBITDA is forecasted to decline to (386.18). Fundamental drivers impacting Instadose Pharma's valuation include:
Price Book 0.0221 | Enterprise Value 757.1 K | Enterprise Value Ebitda (1.28) |
Overvalued
Today
Please note that Instadose Pharma's price fluctuation is very steady at this time. Calculation of the real value of Instadose Pharma Corp is based on 3 months time horizon. Increasing Instadose Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Instadose stock is determined by what a typical buyer is willing to pay for full or partial control of Instadose Pharma Corp. Since Instadose Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Instadose Stock. However, Instadose Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0011 | Real 9.24E-4 | Hype 0.0011 | Naive 0.0011 |
The real value of Instadose Stock, also known as its intrinsic value, is the underlying worth of Instadose Pharma Corp Company, which is reflected in its stock price. It is based on Instadose Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Instadose Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Instadose Pharma Corp helps investors to forecast how Instadose stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Instadose Pharma more accurately as focusing exclusively on Instadose Pharma's fundamentals will not take into account other important factors: Instadose Pharma Corp Company Current Valuation Analysis
Instadose Pharma's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Instadose Pharma Current Valuation | 757.11 K |
Most of Instadose Pharma's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Instadose Pharma Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Instadose Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Instadose Pharma is extremely important. It helps to project a fair market value of Instadose Stock properly, considering its historical fundamentals such as Current Valuation. Since Instadose Pharma's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Instadose Pharma's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Instadose Pharma's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Instadose Pharma Corp has a Current Valuation of 757.11 K. This is 99.99% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Instadose Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Instadose Pharma's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Instadose Pharma could also be used in its relative valuation, which is a method of valuing Instadose Pharma by comparing valuation metrics of similar companies.Instadose Pharma is currently under evaluation in current valuation category among its peers.
Instadose Pharma Current Valuation Drivers
We derive many important indicators used in calculating different scores of Instadose Pharma from analyzing Instadose Pharma's financial statements. These drivers represent accounts that assess Instadose Pharma's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Instadose Pharma's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Enterprise Value | 7.4M | 7.4M | 7.4M | 1.8B | 1.7B | 1.7B |
Instadose Fundamentals
| Return On Asset | -694.06 | ||||
| Current Valuation | 757.11 K | ||||
| Shares Outstanding | 531.93 M | ||||
| Shares Owned By Insiders | 34.03 % | ||||
| Price To Book | 0.02 X | ||||
| EBITDA | (462.02 K) | ||||
| Net Income | 462.02 K | ||||
| Cash And Equivalents | 5.33 K | ||||
| Total Debt | 162.3 K | ||||
| Debt To Equity | 0.01 % | ||||
| Book Value Per Share | 0.07 X | ||||
| Cash Flow From Operations | (65) | ||||
| Earnings Per Share | (0.01) X | ||||
| Beta | -945.3 | ||||
| Market Capitalization | 585.13 K | ||||
| Retained Earnings | (568.38 K) | ||||
| Working Capital | (162.3 K) | ||||
| Year To Date Return | 9.44 % | ||||
| One Year Return | 9.44 % | ||||
| Equity Positions Weight | 99.58 % |
About Instadose Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Instadose Pharma Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Instadose Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Instadose Pharma Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Instadose Pharma Corp is a strong investment it is important to analyze Instadose Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Instadose Pharma's future performance. For an informed investment choice regarding Instadose Stock, refer to the following important reports:Check out Instadose Pharma Piotroski F Score and Instadose Pharma Altman Z Score analysis. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instadose Pharma. If investors know Instadose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instadose Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.01) | Return On Assets (694.06) |
The market value of Instadose Pharma Corp is measured differently than its book value, which is the value of Instadose that is recorded on the company's balance sheet. Investors also form their own opinion of Instadose Pharma's value that differs from its market value or its book value, called intrinsic value, which is Instadose Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instadose Pharma's market value can be influenced by many factors that don't directly affect Instadose Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Instadose Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instadose Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instadose Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.